These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19032173)

  • 41. Piperacillin pharmacokinetics in pediatric patients.
    Wilson CB; Koup JR; Opheim KE; Adelman LA; Levy J; Stull TL; Clausen C; Smith AL
    Antimicrob Agents Chemother; 1982 Sep; 22(3):442-7. PubMed ID: 6215893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In healthy volunteers, taking flucloxacillin with food does not compromise effective plasma concentrations in most circumstances.
    Gardiner SJ; Drennan PG; Begg R; Zhang M; Green JK; Isenman HL; Everts RJ; Chambers ST; Begg EJ
    PLoS One; 2018; 13(7):e0199370. PubMed ID: 30001392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates.
    Pullen J; de Rozario L; Stolk LM; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Jun; 28(3):351-8. PubMed ID: 16778719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol.
    Gross AS; McLachlan AJ; Minns I; Beal JB; Tett SE
    Br J Clin Pharmacol; 2001 Jun; 51(6):547-55. PubMed ID: 11422014
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis.
    Leder K; Turnidge JD; Korman TM; Grayson ML
    J Antimicrob Chemother; 1999 Jan; 43(1):113-8. PubMed ID: 10381108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam during high volume haemodiafiltration in patients with septic shock.
    Tamme K; Oselin K; Kipper K; Tasa T; Metsvaht T; Karjagin J; Herodes K; Kern H; Starkopf J
    Acta Anaesthesiol Scand; 2016 Feb; 60(2):230-40. PubMed ID: 26830215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial.
    Bao H; Lv Y; Wang D; Xue J; Yan Z
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):459-466. PubMed ID: 27796647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1988; 21(4):337-42. PubMed ID: 3370743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of piperacillin in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration.
    Sinnollareddy MG; Roberts MS; Lipman J; Peake SL; Roberts JA
    J Antimicrob Chemother; 2018 Jun; 73(6):1647-1650. PubMed ID: 29506150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling.
    Bergen PJ; Bulitta JB; Kirkpatrick CM; Rogers KE; McGregor MJ; Wallis SC; Paterson DL; Lipman J; Roberts JA; Landersdorfer CB
    J Antimicrob Chemother; 2016 Sep; 71(9):2509-20. PubMed ID: 27231278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of cytochrome P450 3A4 and P-glycoprotein by the isoxazolyl-penicillin antibiotic flucloxacillin.
    Huwyler J; Wright MB; Gutmann H; Drewe J
    Curr Drug Metab; 2006 Feb; 7(2):119-26. PubMed ID: 16472102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Probenecid and food effects on flucloxacillin pharmacokinetics and pharmacodynamics in healthy volunteers.
    Everts RJ; Begg R; Gardiner SJ; Zhang M; Turnidge J; Chambers ST; Begg EJ
    J Infect; 2020 Jan; 80(1):42-53. PubMed ID: 31521742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous determination of flucloxacillin and ampicillin in human plasma by ultra performance liquid chromatography-tandem mass spectrometry and subsequent application to a clinical study in healthy Chinese volunteers.
    Huang C; Gao J; Miao L
    J Pharm Biomed Anal; 2012 Feb; 59():157-61. PubMed ID: 22040729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The simplified oral flucloxacillin absorption test: an accurate method to identify patients with inadequate oral flucloxacillin absorption.
    Dijkmans AC; Kweekel DM; Balmforth C; van Esdonk MJ; van Dissel JT; Burggraaf J; Kamerling IMC
    Neth J Med; 2019 Sep; 77(7):255-260. PubMed ID: 31582580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Saturable elimination of piperacillin in critically ill patients: implications for continuous infusion.
    Dhaese SAM; Colin P; Willems H; Heffernan A; Gadeyne B; Van Vooren S; Depuydt P; Hoste E; Stove V; Verstraete AG; Lipman J; Roberts JA; De Waele JJ
    Int J Antimicrob Agents; 2019 Dec; 54(6):741-749. PubMed ID: 31479741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion.
    Esteve-Pitarch E; Padullés-Zamora A; Maisterra-Santos K; Colom-Codina H; Cobo-Sacristán S
    Farm Hosp; 2019 Sep; 43(5):151-157. PubMed ID: 31469627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
    Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA
    Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between plasma and bone concentrations of cefuroxime and flucloxacillin. Three different parenteral administrations compared in 30 arthroplasties.
    Alvarez Ferrero MM; Vree TB; Van Ewijk-Beneken Kolmer EW; Slooff TJ
    Biopharm Drug Dispos; 1994 Oct; 15(7):599-608. PubMed ID: 7849235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients.
    Smith CL; Milliken S; Powles R; Da Costa F; Gore M; Benjamin S; Talbot D; Ellis L; Large J; Jameson B
    Br J Haematol; 1990 Dec; 76 Suppl 2():6-9. PubMed ID: 2149055
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations.
    Jager NGL; van Hest RM; Xie J; Wong G; Ulldemolins M; Brüggemann RJM; Lipman J; Roberts JA
    J Antimicrob Chemother; 2020 Sep; 75(9):2641-2649. PubMed ID: 32443147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.